Christina Cognata-Smith

Oprichter bij DAS Therapeutics, Inc.

Health Technology

Oorsprong van het eerstegraads netwerk van Christina Cognata-Smith

Entiteit	Type entiteit	Industrie
DAS Therapeutics, Inc. DAS Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology DAS Therapeutics, Inc. is a clinical stage pharmaceutical company. It acquires and develops assets for conditions overlooked or under-served by current treatment approaches to improve patient outcomes. The company was founded by Raimonds Dzelme, Christina Cognata-Smith and Michael Nemmers in 2016 and is headquartered in Boston, MA. 4	Private Company	Pharmaceuticals: Major	4

Grafiek van bedrijven verbonden in de tweede graad

Connectie in verschillende bedrijven

Bedrijven verbonden met Christina Cognata-Smith via zijn persoonlijke netwerk

Onderneming	Sector	Gelieerde personen	Hoofdpost
ELI LILLY AND COMPANY	Pharmaceuticals: Major	Raimonds Dzelme	Corporate Officer/Principal
GT BIOPHARMA, INC.	Pharmaceuticals: Major	Kathleen Clarence-Smith	Chief Executive Officer
TargetRx, Inc. TargetRx, Inc. Miscellaneous Commercial ServicesCommercial Services TargetRx, Inc. provides pharmaceutical and biotech enterprises with insight into the drivers of prescribing. The firm offers various solutions, which include forecasting, positioning, and promotional decisions for new drug launches; optimizing marketing messages and materials for campaign development; and measurement and optimization of execution for sales and marketing execution. TargetRx was founded by Michael J. Luby and Sangam Pant in 1999 and is headquartered in Horsham, PA.	Miscellaneous Commercial Services	Raimonds Dzelme	Corporate Officer/Principal
SANOFI	Pharmaceuticals: Major	Kathleen Clarence-Smith	Corporate Officer/Principal
Prestwick Pharmaceuticals, Inc. Prestwick Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Prestwick Pharmaceuticals, Inc. develops drugs for diseases related to the central nervous system. Its drugs are used in curing diseases such as Huntington's, Parkinson's, restless legs syndrome, schizophrenia, autism, Alzheimer's, and sleep apnea diseases. The company was founded in 2002 and is headquartered in Washington DC.	Pharmaceuticals: Major	Kathleen Clarence-Smith	Founder
COLLEGIUM PHARMACEUTICAL, INC.	Pharmaceuticals: Major	Raimonds Dzelme	Corporate Officer/Principal
Thunderbird School of Global Management	College/University	Raimonds Dzelme	Masters Business Admin
Hoffmann-La Roche, Inc. Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ.	Biotechnology	Kathleen Clarence-Smith	Corporate Officer/Principal
Pacific University	College/University	Raimonds Dzelme	Undergraduate Degree
Université François-Rabelais de Tours	College/University	Kathleen Clarence-Smith	Doctorate Degree
American Academy of Neurology American Academy of Neurology Miscellaneous Commercial ServicesCommercial Services American Academy of Neurology operates a professional society which represents neurologists and neuroscientists. The company was founded in 1948 and is headquartered in Minneapolis, MN.	Miscellaneous Commercial Services	Kathleen Clarence-Smith	Corporate Officer/Principal
Lundbeck, Inc. Lundbeck, Inc. Pharmaceuticals: MajorHealth Technology Part of Lundbeck Foundation, Lundbeck, Inc. is a pharmaceutical company that produces pharmaceutical preparations. The company is based in Paramus, NJ. The company was founded by Jeffrey S. Aronin.	Pharmaceuticals: Major	Raimonds Dzelme	Sales & Marketing
Km Pharmaceutical Consulting LLC		Kathleen Clarence-Smith	Founder
Prestwick Scientific Capital, Inc.		Kathleen Clarence-Smith	Founder
Prestwick Chemical, Inc.		Kathleen Clarence-Smith	Founder
Saatchi & Saatchi Healthcare SA		Raimonds Dzelme	Corporate Officer/Principal
OXIS Biotech, Inc. OXIS Biotech, Inc. BiotechnologyHealth Technology OXIS Biotech, Inc. develops innovative drugs for the treatment of cancer. It also focuses on developing drugs for the treatment of other unmet medical needs. The company was founded by Kathleen E. Clarence-Smith on September 26, 2014 and is headquartered in Tampa, FL.	Biotechnology	Kathleen Clarence-Smith	Founder
Georgetown Translational Pharmaceuticals, Inc. Georgetown Translational Pharmaceuticals, Inc. Hospital/Nursing ManagementHealth Services Georgetown Translational Pharmaceuticals, Inc. provides treatment for neuropathic pain, refractory epilepsies, the symptoms of myasthenia gravis, and motion sickness. The company was founded by Kathleen Clarence-Smith and Mark J. Silverman and is headquartered in United States.	Hospital/Nursing Management	Kathleen Clarence-Smith	Founder
Chase Therapeutics Corp. Chase Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Chase Therapeutics Corp. operates as healthcare company. The company was founded in 2017 and is headquartered in Washington, DC.	Pharmaceuticals: Major	Kathleen Clarence-Smith	Chairman
Riverside Pharmaceuticals Corp.	Miscellaneous	Kathleen Clarence-Smith	Director/Board Member
Westhaven Therapeutics Corp.		Kathleen Clarence-Smith	Director/Board Member

Statistieken

Internationaal

Verenigde Staten	22
Frankrijk	4
Italië	2

Sectoraal

Health Technology	11
Commercial Services	5
Consumer Services	4
Finance	2
Health Services	2

Operationeel

Corporate Officer/Principal	12
Founder	9
Director/Board Member	7
Chairman	2
Chief Executive Officer	2

Sterkste connecties

Insiders
Kathleen Clarence-Smith	17
Raimonds Dzelme	10
Michael Nemmers	1
Frederic Krohn	1

Alle connecties tonen